Skip to content

HSCSW

HeartSciences Inc.

NASDAQ · Healthcare · Medical - Devices · US

$0.07
+44.89%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-7.6%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jan 12, 2026Wells David R. · directorA-Award15,000$0.00
Jan 12, 2026Bent Bruce · directorA-Award15,000$0.00
Dec 22, 2025HILZ MARK T · officer: See RemarksA-Award45,000$0.00
Dec 22, 2025Szymczak Brian · directorA-Award15,000$0.00
Dec 22, 2025Watson Danielle · officer: See RemarksA-Award15,000$0.00
Nov 28, 2025Simpson Andrew · director, officer: See RemarksA-Award70,000$0.00
Jul 30, 2025HILZ MARK T · director, officer: COO, Secretary and DirectorSale4,416$3.54
Jul 14, 2025Bent Bruce · directorA-Award25,000$4.37
Jul 11, 2025Szymczak Brian · directorA-Award25,000$4.37
Jul 11, 2025Simpson Andrew · director, officer: See RemarksA-Award275,000$4.37
Jul 11, 2025Simpson Andrew · director, officer: See RemarksA-Award68,750$0.00
Jul 11, 2025Wells David R. · directorA-Award25,000$4.37
Jul 11, 2025HILZ MARK T · director, officer: See RemarksA-Award225,000$4.37
Jul 11, 2025HILZ MARK T · director, officer: See RemarksA-Award56,250$0.00
Jul 11, 2025Watson Danielle · officer: See RemarksA-Award25,000$4.37
Jan 23, 2025Bent Bruce · directorA-Award6,000$3.33
Jan 21, 2025HILZ MARK T · director, officer: See RemarksA-Award45,000$3.33
Jan 21, 2025Wells David R. · directorA-Award6,000$3.33
Jan 21, 2025Watson Danielle · officer: See RemarksA-Award9,000$3.33
Jan 21, 2025Szymczak Brian · directorA-Award6,000$3.33
Jan 21, 2025Simpson Andrew · director, officer: See RemarksA-Award45,000$3.33
Institutional positioning

13F filings over the trailing two quarters

New 0Increased 1Reduced 2Sold out 2
FilerActionSharesFiled
CLEAR STREET GROUP INC.Unchanged270,770May 15, 2026
CITADEL ADVISORS LLCReduced192,587May 15, 2026
CITADEL ADVISORS LLCReduced187,495Sep 2, 2026
UBS GROUP AGIncreased1,086May 5, 2026
UBS Group AGSold Out0May 5, 2026
Clear Street Group Inc.Sold Out0May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jan 12, 2026